Nicotinic acid adenine dinucleotide phosphate

Nicotinic acid adenine dinucleotide phosphate
Identifiers
CAS number	5502-96-5 Y
PubChem	123953
IUPHAR ligand	2450
Properties
Molecular formula	[C21H28N6O18P3]+
Molar mass	745.398 g/mol
Y (verify) (what is: Y/N?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

Nicotinic acid adenine dinucleotide phosphate, (NAADP), is a Ca²⁺-mobilizing second messenger synthesised in response to extracellular stimuli. Like its mechanistic cousins, IP₃ and cyclic adenosine diphosphoribose (Cyclic ADP-ribose) , NAADP binds to and opens Ca²⁺ channels on intracellular organelles, thereby increasing the intracellular Ca²⁺ concentration which, in turn, modulates sundry cellular processes (see Calcium signalling). Structurally, it is a dinucleotide that only differs from the house-keeping enzyme cofactor, NADP by a hydroxyl group (replacing the nicotinamide amino group) and yet this minor modification converts it into the most potent Ca²⁺-mobilizing second messenger yet described. NAADP acts across phyla from plants to man.

Discovery

Cell stimuli select different Ca²⁺ stores by synthesising different second messengers. Shown for comparison are the ER-targeting messengers, IP₃ and cADPR.

In their landmark 1987 paper, Hon Cheung Lee and colleagues discovered not one but two Ca²⁺-mobilizing second messengers, cADPR and NAADP from the effects of nucleotides on Ca²⁺ release in sea urchin egg homogenates. It turns out that NAADP was a contaminant in commercial sources of NADP, but it wasn't until 1995 that its structure was solved . The first demonstration that NAADP could act in mammalian cells (pancreas) came four years later . Subsequently, NAADP has been detected in sources as diverse as human sperm, red and white blood cells, liver, and pancreas, to name but a few.

Synthesis & Degradation

Speculative pathways for NAADP synthesis and degradation. ADP-ribosyl cyclase (ARC) family members (such as CD38) can synthesise NAADP via the base-exchange reaction (NicAcid, Nicotinic Acid; NiAm, nicotinamide). NAADP may be broken down to NAAD via a Ca²⁺-sensitive phosphatase, or to 2-phosphoadenosine diphosphoribose (ADPRP) by CD38 itself. For simplicity, enzyme topology has been ignored (see below).

Kinetics & Transduction

The first demonstration that NAADP levels increase in response to an extracellular stimulus arose from studying sea urchin fertilization (NAADP changed in both the eggs and sperm upon contact). Subsequently, other cell types have followed suit, as exemplified by the pancreas (acinar and beta cells), T-cells, and smooth muscle. Levels increase very rapidly — and possibly precede the increase in the other messengers IP₃ and cADPR — but can be very transient (spiking and returning to basal levels within seconds). The transduction mechanisms that couple cell stimuli to such NAADP increases are ill-defined, with some suggestions of cyclic AMP or cytosolic Ca²⁺ itself stimulating synthesis.

Synthetic Enzymes

Regardless of the details, an outstanding issue is that the physiological route of NAADP synthesis has still not been unequivocally identified — neither the reaction(s) nor the enzyme(s). Clearly, it is theoretically possible there may be multiple routes of synthesis, but this would be unprecedented in the second messenger world. To date, the most favoured hypothesis is the so-called base-exchange reaction (nicotinic acid + NADP → NAADP + nicotinamide; catalyzed by ADP-ribosyl cyclases) which are a family of enzymes that include CD38 and CD157 in mammals (and orthologs in sea urchin and Aplysia ovotestis). These were first discovered as the synthetic enzymes for cADPR but later revealed to be multifunctional, promiscuous enzymes that can also produce NAADP. Certainly NAADP production can occur in vitro but whether it occurs in vivo is another question (because genetic knockout or knock-down of ADP-ribosyl cyclases has no effect on NAADP production in some cell types) , and there may be other routes which require different substrates and enzymes .

Degradative Enzymes

Like any second messenger system, the signal must be terminated and there must be routes for NAADP removal but again, little is known with any degree of certainty. A 2'-3'-phosphatase stimulated by Ca²⁺ has been proposed in brain and, possibly in pancreatic acinar cells, that catabolises NAADP to inactive NAAD. More recently, CD38 has also been proposed to breakdown NAADP (to ADPRP — see inset). NAADP may also be reduced to NAADPH.

Target Organelle

In contrast to IP3 and cyclic ADP-ribose which predominantly mobilize Ca²⁺ from the neutral and abundant endoplasmic reticulum (ER) store, NAADP selectively targets acidic Ca²⁺ stores — usually less abundant than the ER but with a pivotal role that belies their size. This paradigm shift away from the ER derives from seminal studies, again in sea urchin egg, that showed NAADP-mediated Ca²⁺ release was sensitive to agents that target acidic organelles (e.g. bafilomycin A1) but was less sensitive to ones that interfere with ER Ca²⁺ storage (e.g. thapsigargin).

Acidic Ca²⁺ store

This is a blanket term that encompasses a spectrum of acidic vesicles that include endosomes, lysosomes, and lysosome-related organelles and secretory vesicles and acidocalcisomes. They are a highly dynamic continuum of vesicles with a rich variety of established biochemical roles in cells, to which Ca²⁺ storage can now be added. Their luminal pH is one characteristic that distinguishes a given vesicle class from another: where endosomes are weakly acidic (pH 6-6.5), lysosomes are typically the most acidic (pH 4.5-5.0) and secretory vesicles are typically pH 5.5. Ca²⁺ is seen to be increasingly important for endo-lysosomal function, e.g. trafficking and autophagy. Aberrations in Ca²⁺ signals can have pathophysiological consequences, including lysosomal storage diseases such as Niemann Pick C and Mucolipidosis IV.

When NAADP mobilizes Ca²⁺ from these stores, the pH of the stores concomitantly increases (becomes more alkaline), as testified by studies in sea urchin egg, mammalian heart and pancreas. Whether this has consequences for vesicle (or NAADP) function remains to be seen, but luminal pH is usually crucial for resident protein activity.

Ca²⁺ Uptake

Simplified pathways regulating luminal Ca²⁺ (left) and pH (right) in acidic organelles. Ca²⁺ uptake can be mediated either by a Ca²⁺/H⁺ exchanger (CHX, that exploits the pH gradient) or a Ca²⁺ pump (powered by ATP hydrolysis). The low luminal pH is driven by the H⁺ pump, the V-ATPase, and aided by essential counterion movements, e.g. chloride uptake, that acts as a charge shunt essential for optimal proton uptake.

In other Ca²⁺-storing organelles such as the endoplasmic reticulum or Golgi, stores are filled by Ca2+-ATPases pumps, typified by the ubiquitous members of the SERCA or the SPCA (secretory pathway Ca²⁺-ATPase) families respectively. Ca²⁺ uptake by acidic stores occurs via other proteins: in yeast and plants (the best understood systems) the acidic vacuoles host two uptake pathways: a high affinity Ca²⁺-ATPase and a low affinity Ca²⁺/H⁺ antiporter (or exchanger, generically denoted as CHX). The pumps are different from the SERCA family (and, importantly, are insensitive to their inhibitor, thapsigargin) whereas the exchanger exploit the H⁺ gradient to drive Ca²⁺ uptake against its concentration gradient. The genes encoding these proteins are well-defined.

In higher organisms, the situation is less clear. Ca²⁺ uptake usually occurs via a thapsigargin-insensitive pathway (therefore precluding SERCA involvement) and appears to be dependent upon the H⁺ gradient; whether this occurs via a single (unknown) CHX or via exchangers in series (e.g. Na⁺/H⁺ exchanger coupled to a Na⁺/Ca²⁺ exchanger) is unproven. Acidic vesicles in some cell types may well take a leaf out of the yeasts'/plants' book and host two uptake pathways, but whether this is a widespread template is unclear.

In the absence of selective Ca²⁺ uptake inhibitors (often because we do not even know the protein/route), it is common to indirectly inhibit Ca²⁺ uptake by collapsing the thermodynamic drive (the H⁺ gradient). The H⁺ gradient can be eliminated either with H⁺ ionophores (protonophores) such as nigericin or monensin or by inhibiting the V-ATPase that generates the H⁺ gradient with compounds such as bafilomycin A1 or concanamycin.

Target Channel (TPCs)

Even from the early pioneering work in sea urchin egg, it was clear from the pharmacological profile that NAADP acted upon a different channel from the IP3 receptor and ryanodine receptor and this has recently been borne out by the molecular identification of the NAADP receptor as members of the TPC (two-pore channel) family. As structural intermediates between single domain TRP and four-domain Voltage-dependent calcium channel, the TPCs form oligomers (possibly dimers) to form the functional Ca2+ channel. Appropriately, these channels reside on acidic organelles (including different classes of endosomes and lysosomes).

Isoforms

There are 3 genes that encode three isoforms of TPC1-3 that differ substantially from each other in their primary sequence (but these differences are preserved across species, such that human and sea urchin TPC1 are more closely related than are human TPC1 and human TPC2). Moreover, the TPC isoforms exhibit different organellar distributions, with TPC1 being found throughout the endo-lysosomal system whereas TPC2 shows a more restricted late-endosomal/lysosomal localization.

NAADP Binding Protein

IP3 binds directly to its cognate IP3 receptor which is therefore a true ligand-gated ion channel. In contrast, NAADP may not bind directly to TPCs but may require an intermediate unknown accessory protein. In sea urchin egg homogenate, the binding protein(s) may be smaller than TPCs themselves, judging by photoaffinity labelling with [³²P]azido-NAADP. Therefore, the NAADP receptor is likely to be a multi-protein complex on acidic vesicles.

Regulatory Factors

Luminal Ions

In addition to NAADP gating the channel, there is some evidence that the luminal pH also affects channel activity, in the case of human TPC2, a more alkaline pH favours channel opening. Furthermore, luminal Ca²⁺ may also sensitize TPC2 to NAADP (analogous to luminal Ca²⁺ regulation of IP3Rs and RyRs), but this demands wider study across isoforms and species.

Cytosolic Ions

To date, the majority of evidence is against the NAADP receptor being regulated by either cytosolic Ca²⁺ or pH.

Pharmacology

NAADP inhibitors

Recently, a selective cell-permeant NAADP antagonist, trans-Ned-19 has been discovered which blocks Ca²⁺ signals and downstream Ca²⁺-dependent processes such as differentiation. Prior to that, only high concentrations of blockers of L-type Ca2+ channels (e.g. diltiazem, dihydropyridines) could be used (with obvious concerns over non-NAADP effects).

Although not true antagonism, the NAADP 'receptor' can self-inactivate when bound to non-releasing concentrations of NAADP itself. Such inactivating pre-pulses of NAADP were the first strategy for implicating NAADP in subsequent physiological pathways.

NAADP activators

NAADP is charged and cannot cross cell membranes. Therefore, an inactive, lipophilic ester precursor (NAADP/AM) has been synthesised which crosses membranes and rapidly regenerates NAADP in the cytosol following the action of endogenous esterases.

Caged NAADP is an inactive, membrane-impermeant analog of NAADP that can be introduced into cells by microinjection or a patch pipette. Flash photolysis with a UV light source rapidly converts this into NAADP, allowing the experimenter to precisely manipulate NAADP levels in time and space .

Ca²⁺ storage

An indirect means of inhibiting NAADP action is to deplete its target Ca²⁺ stores. As noted above, this usually entails collapsing the H⁺ gradient with either V-ATPase inhibitors (e.g. Bafilomycin A1) or protonophores (e.g. nigericin or monensin). In platelets it has been suggested that SERCA3 inhibition with tBHQ can also abrogate NAADP-dependent signals.

Transport

The two paralogous enzymes- transmembrane CD38 and GPI anchored CD157, that produce NAADP (and cADPR) in humans both have their active synthesis site in the ectodomain. Though this may involve vesicular synthesis but it has been shown that it is produced at the extracellular sites, and also can act when produced by a different cell or added artificially from outside. So the NAADP has to enter the cell either by diffusion or by transport. Considering the fact that the substrate of NAADP synthesis (NADP) itself is very sparse in the extracellular medium, a purse diffusion based mechanism has been suspected to be less likely than a transporter mediated path. This is compatible with recent data which indicate a carrier mediated transport partially blockable by dipyridamole and cold temperature.

See also

• Cyclic ADP-ribose
• IP3

References

Lee, H.C. and Aarhus, R. (1995) A derivative of NADP mobilizes calcium stores insensitive to inositol trisphosphate and cyclic ADP-ribose. J. Biol. Chem. 270, 2152-2157.